Personalized Medication Software for BCL-2 Inhibitor in AML Patients Using Machine Learning and Genomics
NCT06295029
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School